Invenomic Capital Management’s Rivian RIVN Stock Holding History

Invenomic Capital Management’s Portfolio RIVN Stock Details RIVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.4M	Buy	+890,000	New	+$14.2M	0.61%	59

Other funds holding RIVN

ACI

Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invenomic Capital Management's RIVN Position: Q2 2025 in Review

Invenomic Capital Management sold out of Rivian (RIVN) in Q2 2025, closing a stake of 709,173 shares — an estimated $8.83M sold.

Invenomic Capital Management first reported a position in RIVN in Q2 2024 and held it in 4 quarters. The position peaked at $8.83M in Q1 2025. 756 funds tracked by Wall St. Rank hold RIVN as of Q2 2025.

Invenomic Capital Management reported no remaining Rivian position as of Q2 2025 after selling out during the quarter.
Invenomic Capital Management sold 709,173 Rivian shares in Q2 2025, an estimated $8.83M.
Invenomic Capital Management first reported a position in Rivian in Q2 2024 and held it in 4 quarters.
Invenomic Capital Management's Rivian position peaked at $8.83M in Q1 2025.
756 funds tracked by Wall St. Rank held Rivian as of Q2 2025.

Based on Invenomic Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.